Code | CSB-EP618761HU |
Abbreviation | Recombinant Human AIMP2 protein |
MSDS | |
Size | US$306 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
The recombinant human AIMP2 protein is a fusion protein consists of the human AIMP2 protein (1-320aa) partnered with the N-terminal 6xHis tag. It was produced in the E.coli. This recombinant AIMP2 protein's purity is greater than 90% determined by SDS-PAGE. After electrophoresis, there is a 30 kDa protein band presented on the gel.
AIMP2 protein encoded by this gene is part of the aminoacyl-tRNA synthetase complex, which contains nine different aminoacyl-tRNA synthetases and three non-enzymatic factors. The encoded protein is one of the non-enzymatic factors and is required for assembly and stability of the complex. AIMP2 had an inhibitory effect on neoplasms, which could increase the tumor necrosis-induced signaling apoptosis. AIMP2 can directly interact with and activate PARP1. Both AIMP2 and α-synuclein are components of Lewy bodies. Likewise, activated PARP1 can regulate several pathological mechanisms in PD, including the aggregation of α-synuclein, mitochondria dysfunction, and mitophagy dysregulation. AIMP2 also inhibits editing by decreasing ADAR protein levels. Recent evidence indicates that PARP1 activation is a necessary early event in DA neuronal cell death induced by 6-OHDA, consistent with the fact that AIMP2-mediated activation of PARP1 is one of the main causes for the loss of DA neurons.
There are currently no reviews for this product.